Business & FinanceHealthcare

Global Infectious Diseases 2019 Market Share, Trends, Segmentation and Forecast to 2025

Press Release adds “Global Infectious Diseases Market Size, Status and Forecast 2019-2025”new report to its research database. The report spread across 108 pages with multiple tables and figures in it. This report studies the Infectious Diseases market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Infectious Diseases market analysis segmented by companies, region, type and applications in the report.

When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.

Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.

In 2018, the global Infectious Diseases market size was — million US$ and it is expected to reach — million US$ by the end of 2025, with a CAGR of –% during 2019-2025.

Request sample copy at

This report focuses on the global Infectious Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Diseases development in United States, Europe and China.

The key players covered in this study

  • Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson and Johnson
  • Merck
  • Pfizer
  • AbbVie
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Bristol-Myers Squibb
  • Chimerix Pharmaceuticals
  • Cubist
  • Eli Lilly
  • Isis Pharmaceuticals
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Sanofi
  • Vertex

Market segment by Type, the product can be split into        

  • Antibacterial drugs
  • Antiviral drugs
  • Antifungal drugs
  • Antiparasitic drugs

Market segment by Application, split into                  

  • Acquired Immune Deficiency Syndrome
  • Hepatitis B
  • Hepatitis C
  • Human Papillomavirus
  • Hospital acquired Methicillin-resistant Staphylococcus aureus infection
  • Chlamydia trachomatis and Neisseria Gonorrhea

Market segment by Regions/Countries, this report covers

United States, Europe, China, Japan, Southeast Asia, India, Central and South America

Browse detail report with in-depth TOC at

The study objectives of this report are:

  • To analyze global Infectious Diseases status, future forecast, growth opportunity, key market and key players.
  • To present the Infectious Diseases development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered estimating the market size of Infectious Diseases are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Purchase Report copy at

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Infectious Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibacterial drugs
1.4.3 Antiviral drugs
1.4.4 Antifungal drugs
1.4.5 Antiparasitic drugs
1.5 Market by Application
1.5.1 Global Infectious Diseases Market Share by Application (2014-2025)
1.5.2 Acquired Immune Deficiency Syndrome
1.5.3 Hepatitis B
1.5.4 Hepatitis C
1.5.5 Human Papillomavirus
1.5.6 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
1.5.7 Chlamydia trachomatis and Neisseria Gonorrhea
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Infectious Diseases Market Size
2.2 Infectious Diseases Growth Trends by Regions
2.2.1 Infectious Diseases Market Size by Regions (2014-2025)
2.2.2 Infectious Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Infectious Diseases Market Size by Manufacturers
3.1.1 Global Infectious Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Infectious Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Infectious Diseases Key Players Head office and Area Served
3.3 Key Players Infectious Diseases Product/Solution/Service
3.4 Date of Enter into Infectious Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans….. To be continues

About Us: is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.

Contact Us

Mr. Jeet Jain

Sales Manager

[email protected]

+91-888-841-3131(IND) | +1-240-284-8070(U.S) | +44-20-3290-4151(U.K)

Connect with us:  Google+ | LinkedIn | Twitter | Facebook


Related Articles